| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Magnetic Resonance Spectroscopy | 15 | 1995 | 74 |
Why?
|
Magnetic Resonance Imaging | 38 | 1987 | 294 |
Why?
|
Brain Neoplasms | 7 | 1986 | 116 |
Why?
|
Contrast Media | 23 | 1983 | 116 |
Why?
|
Image Processing, Computer-Assisted | 14 | 1991 | 138 |
Why?
|
Glioma | 4 | 1986 | 51 |
Why?
|
Brain | 32 | 1986 | 305 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2003 | 25 |
Why?
|
Phantoms, Imaging | 13 | 1995 | 41 |
Why?
|
Multiple Sclerosis | 4 | 1996 | 43 |
Why?
|
Glioblastoma | 3 | 1988 | 44 |
Why?
|
Aspartic Acid | 4 | 2001 | 37 |
Why?
|
Hippocampus | 10 | 1983 | 83 |
Why?
|
Metrizamide | 16 | 1983 | 4 |
Why?
|
Hydrocephalus, Normal Pressure | 4 | 1992 | 2 |
Why?
|
Middle Aged | 53 | 1980 | 1161 |
Why?
|
Perfusion Imaging | 2 | 2009 | 10 |
Why?
|
Diffusion Tensor Imaging | 2 | 2009 | 13 |
Why?
|
Tomography, X-Ray Computed | 19 | 1980 | 321 |
Why?
|
Male | 68 | 1980 | 1553 |
Why?
|
Spinal Cord | 6 | 1984 | 94 |
Why?
|
Dementia, Vascular | 2 | 2002 | 4 |
Why?
|
Humans | 92 | 1980 | 1856 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2011 | 9 |
Why?
|
Perfusion | 2 | 1986 | 73 |
Why?
|
Supratentorial Neoplasms | 1 | 2011 | 7 |
Why?
|
Female | 62 | 1980 | 1643 |
Why?
|
Nerve Fibers, Myelinated | 3 | 2002 | 18 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2010 | 20 |
Why?
|
Radiotherapy, Conformal | 1 | 2010 | 12 |
Why?
|
Blood Volume | 1 | 2010 | 35 |
Why?
|
Dacarbazine | 1 | 2010 | 18 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 1999 | 17 |
Why?
|
Adult | 44 | 1980 | 1317 |
Why?
|
Adenocarcinoma | 5 | 1980 | 167 |
Why?
|
Triiodobenzoic Acids | 12 | 1983 | 6 |
Why?
|
Spinal Cord Neoplasms | 1 | 2009 | 17 |
Why?
|
Aged | 38 | 1980 | 988 |
Why?
|
Gadolinium DTPA | 4 | 1991 | 35 |
Why?
|
Iohexol | 16 | 1983 | 17 |
Why?
|
Glucose | 10 | 1983 | 120 |
Why?
|
Hydroxyquinolines | 2 | 1996 | 5 |
Why?
|
Adjuvants, Immunologic | 2 | 1996 | 73 |
Why?
|
Iodobenzoates | 7 | 1983 | 5 |
Why?
|
Reproducibility of Results | 11 | 1996 | 391 |
Why?
|
Cerebrovascular Disorders | 7 | 1995 | 66 |
Why?
|
Myelography | 8 | 1984 | 5 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2003 | 3 |
Why?
|
Synaptosomes | 4 | 1989 | 7 |
Why?
|
Aged, 80 and over | 15 | 1992 | 599 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 1991 | 33 |
Why?
|
Soft Tissue Neoplasms | 1 | 2001 | 35 |
Why?
|
Central Nervous System Diseases | 2 | 1985 | 33 |
Why?
|
Image Enhancement | 5 | 1987 | 70 |
Why?
|
Pentetic Acid | 4 | 1986 | 26 |
Why?
|
Organometallic Compounds | 3 | 1991 | 40 |
Why?
|
Head and Neck Neoplasms | 1 | 2001 | 47 |
Why?
|
Temporal Lobe | 6 | 1989 | 41 |
Why?
|
Mitomycins | 3 | 1980 | 13 |
Why?
|
Computer Simulation | 5 | 1998 | 134 |
Why?
|
Carcinoma, Squamous Cell | 4 | 1980 | 111 |
Why?
|
Brain Mapping | 7 | 1991 | 61 |
Why?
|
Radiation Protection | 1 | 1998 | 17 |
Why?
|
Gadolinium | 2 | 1991 | 15 |
Why?
|
Creatine | 3 | 2001 | 18 |
Why?
|
Choline | 3 | 2001 | 24 |
Why?
|
Reference Values | 5 | 1998 | 278 |
Why?
|
Body Composition | 1 | 1998 | 44 |
Why?
|
Cerebral Cortex | 3 | 1990 | 108 |
Why?
|
Sodium Chloride | 2 | 1994 | 77 |
Why?
|
Carotid Stenosis | 2 | 1996 | 33 |
Why?
|
Dementia | 2 | 1988 | 56 |
Why?
|
Phosphatidylinositols | 3 | 1990 | 17 |
Why?
|
Retrospective Studies | 10 | 1980 | 653 |
Why?
|
Sensitivity and Specificity | 5 | 1999 | 427 |
Why?
|
Signal Processing, Computer-Assisted | 5 | 1991 | 39 |
Why?
|
Preoperative Care | 4 | 1986 | 93 |
Why?
|
Models, Structural | 2 | 1995 | 42 |
Why?
|
Deoxyglucose | 3 | 1989 | 17 |
Why?
|
Iopamidol | 5 | 1986 | 4 |
Why?
|
Lung Neoplasms | 3 | 1980 | 159 |
Why?
|
Vectorcardiography | 1 | 1994 | 3 |
Why?
|
Diagnostic Imaging | 2 | 1996 | 66 |
Why?
|
Cerebrovascular Circulation | 3 | 1996 | 62 |
Why?
|
Blood-Brain Barrier | 3 | 1988 | 63 |
Why?
|
Poliomyelitis | 1 | 1993 | 5 |
Why?
|
Follow-Up Studies | 9 | 1987 | 553 |
Why?
|
Deoxy Sugars | 2 | 1989 | 5 |
Why?
|
Brain Diseases | 3 | 1991 | 75 |
Why?
|
Muscular Atrophy | 1 | 1993 | 14 |
Why?
|
Observer Variation | 3 | 1996 | 103 |
Why?
|
Paralysis | 1 | 1993 | 37 |
Why?
|
Pneumonia, Viral | 1 | 1993 | 17 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 1992 | 8 |
Why?
|
Nose Neoplasms | 1 | 1992 | 12 |
Why?
|
Regression Analysis | 2 | 1998 | 256 |
Why?
|
Herpes Simplex | 1 | 1993 | 31 |
Why?
|
Phosphoric Acids | 3 | 1995 | 2 |
Why?
|
Frontal Lobe | 3 | 1998 | 33 |
Why?
|
Carcinoma, Bronchogenic | 2 | 1980 | 17 |
Why?
|
Adolescent | 10 | 1984 | 891 |
Why?
|
Double-Blind Method | 6 | 1983 | 274 |
Why?
|
Coronary Disease | 1 | 1994 | 94 |
Why?
|
Animals | 21 | 1983 | 1031 |
Why?
|
Dobutamine | 1 | 2011 | 19 |
Why?
|
Cardiac Output | 1 | 2011 | 48 |
Why?
|
Coronary Angiography | 2 | 1986 | 49 |
Why?
|
Swine | 1 | 2011 | 95 |
Why?
|
Cognition Disorders | 2 | 2003 | 107 |
Why?
|
Postoperative Complications | 3 | 2001 | 305 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 279 |
Why?
|
Jejunal Neoplasms | 2 | 1980 | 4 |
Why?
|
Ileal Neoplasms | 2 | 1980 | 6 |
Why?
|
Aorta | 1 | 2011 | 69 |
Why?
|
Rats, Inbred Strains | 9 | 1983 | 170 |
Why?
|
Leukoencephalopathies | 1 | 2009 | 5 |
Why?
|
Functional Laterality | 2 | 2002 | 50 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2010 | 30 |
Why?
|
Heart Ventricles | 1 | 2011 | 86 |
Why?
|
Phosphorus Isotopes | 3 | 1995 | 9 |
Why?
|
Prognosis | 3 | 1995 | 388 |
Why?
|
Subarachnoid Hemorrhage | 2 | 1996 | 15 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 112 |
Why?
|
Epilepsy | 1 | 1991 | 49 |
Why?
|
Young Adult | 2 | 2010 | 380 |
Why?
|
Thoracic Vertebrae | 2 | 1993 | 21 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 58 |
Why?
|
Biopsy | 1 | 2010 | 207 |
Why?
|
Bronchial Arteries | 3 | 1980 | 4 |
Why?
|
Infusions, Intra-Arterial | 3 | 1980 | 12 |
Why?
|
Time Factors | 5 | 2000 | 896 |
Why?
|
Glycoproteins | 1 | 2010 | 113 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 51 |
Why?
|
Carotid Artery, Common | 2 | 1996 | 23 |
Why?
|
Algorithms | 2 | 2001 | 226 |
Why?
|
Skin | 3 | 1995 | 177 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2008 | 19 |
Why?
|
Brain Ischemia | 2 | 1991 | 45 |
Why?
|
Treatment Outcome | 3 | 1996 | 661 |
Why?
|
Hemiplegia | 2 | 1997 | 14 |
Why?
|
Cauda Equina | 1 | 1987 | 3 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1992 | 121 |
Why?
|
Survival Analysis | 1 | 2010 | 205 |
Why?
|
Muscle, Skeletal | 3 | 1998 | 114 |
Why?
|
Survival Rate | 1 | 2010 | 250 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 1987 | 8 |
Why?
|
Rats | 11 | 1983 | 530 |
Why?
|
Incidence | 1 | 2010 | 336 |
Why?
|
Neck | 1 | 2007 | 31 |
Why?
|
Heart Failure | 1 | 2011 | 106 |
Why?
|
Nerve Tissue | 1 | 1986 | 7 |
Why?
|
Prospective Studies | 8 | 1992 | 545 |
Why?
|
Recurrence | 3 | 1996 | 261 |
Why?
|
Echo-Planar Imaging | 1 | 2006 | 10 |
Why?
|
Electroencephalography | 2 | 1991 | 88 |
Why?
|
Quality Control | 3 | 1987 | 54 |
Why?
|
Parietal Bone | 1 | 1986 | 7 |
Why?
|
Subtraction Technique | 1 | 1986 | 13 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 1986 | 6 |
Why?
|
Attention | 2 | 1997 | 64 |
Why?
|
Brain Abscess | 1 | 1986 | 12 |
Why?
|
Fetal Monitoring | 1 | 1986 | 8 |
Why?
|
Cytokines | 3 | 1997 | 207 |
Why?
|
Sweden | 5 | 1980 | 13 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1988 | 85 |
Why?
|
Osteomyelitis | 1 | 1986 | 39 |
Why?
|
Artifacts | 3 | 1995 | 34 |
Why?
|
Auditory Cortex | 1 | 2006 | 18 |
Why?
|
Phosphocreatine | 2 | 2001 | 11 |
Why?
|
Rabbits | 7 | 1984 | 252 |
Why?
|
Evaluation Studies as Topic | 2 | 1995 | 178 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 2 | 1988 | 7 |
Why?
|
Ventricular Fibrillation | 1 | 1986 | 24 |
Why?
|
Dominance, Cerebral | 3 | 1997 | 34 |
Why?
|
Myelin Sheath | 1 | 2005 | 30 |
Why?
|
Intervertebral Disc | 1 | 2004 | 10 |
Why?
|
Bone Cements | 1 | 2004 | 9 |
Why?
|
Fractures, Spontaneous | 1 | 2004 | 12 |
Why?
|
Surgical Procedures, Minimally Invasive | 1 | 2004 | 23 |
Why?
|
Polymethyl Methacrylate | 1 | 2004 | 13 |
Why?
|
Postpoliomyelitis Syndrome | 1 | 2003 | 1 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 46 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2003 | 4 |
Why?
|
Muscle Fatigue | 1 | 2003 | 10 |
Why?
|
Spinal Fractures | 1 | 2004 | 24 |
Why?
|
Anisotropy | 3 | 2006 | 23 |
Why?
|
Lumbar Vertebrae | 1 | 2004 | 43 |
Why?
|
Diatrizoate Meglumine | 4 | 1983 | 14 |
Why?
|
Osteoporosis | 1 | 2004 | 47 |
Why?
|
Violence | 2 | 2000 | 31 |
Why?
|
Touch | 1 | 2002 | 10 |
Why?
|
Mechanoreceptors | 1 | 2002 | 9 |
Why?
|
Antigens, CD95 | 2 | 1999 | 16 |
Why?
|
Neurologic Examination | 5 | 1984 | 64 |
Why?
|
Afferent Pathways | 1 | 2002 | 24 |
Why?
|
Antisocial Personality Disorder | 1 | 2002 | 14 |
Why?
|
Prisoners | 1 | 2002 | 10 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2002 | 5 |
Why?
|
Nerve Fibers | 1 | 2002 | 45 |
Why?
|
Heterocyclic Compounds | 2 | 1991 | 11 |
Why?
|
Acyclovir | 1 | 2002 | 28 |
Why?
|
Stroke | 2 | 2000 | 59 |
Why?
|
Valine | 1 | 2002 | 27 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2001 | 12 |
Why?
|
Osmolar Concentration | 4 | 1985 | 91 |
Why?
|
Demyelinating Diseases | 1 | 2002 | 28 |
Why?
|
Back Pain | 1 | 2001 | 24 |
Why?
|
Brain Stem | 1 | 2001 | 50 |
Why?
|
Bronchial Neoplasms | 1 | 1980 | 8 |
Why?
|
Radiation Dosage | 2 | 1996 | 65 |
Why?
|
Posterior Cerebral Artery | 1 | 2000 | 2 |
Why?
|
Adipose Tissue | 2 | 1998 | 80 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2000 | 8 |
Why?
|
Axons | 1 | 2002 | 66 |
Why?
|
Collateral Circulation | 2 | 1996 | 13 |
Why?
|
Spinal Fusion | 1 | 2001 | 24 |
Why?
|
Scoliosis | 1 | 2001 | 20 |
Why?
|
Fourier Analysis | 2 | 1995 | 23 |
Why?
|
Subarachnoid Space | 6 | 1984 | 8 |
Why?
|
Brain Damage, Chronic | 1 | 2000 | 23 |
Why?
|
Questionnaires | 3 | 1996 | 360 |
Why?
|
Neurofibroma | 1 | 1980 | 4 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 1980 | 2 |
Why?
|
Impulsive Behavior | 1 | 2000 | 11 |
Why?
|
Phosphorus | 2 | 1995 | 29 |
Why?
|
Risk Assessment | 2 | 2000 | 324 |
Why?
|
Carcinoid Tumor | 1 | 1980 | 20 |
Why?
|
Leg | 2 | 1984 | 75 |
Why?
|
Antiviral Agents | 1 | 2002 | 91 |
Why?
|
Outcome Assessment (Health Care) | 1 | 2002 | 163 |
Why?
|
Leiomyoma | 1 | 1980 | 34 |
Why?
|
Cerebrospinal Fluid | 2 | 1986 | 23 |
Why?
|
Carcinoma | 1 | 1980 | 109 |
Why?
|
Hypertension | 1 | 2002 | 161 |
Why?
|
Radiometry | 1 | 1998 | 31 |
Why?
|
Mental Disorders | 1 | 2002 | 132 |
Why?
|
Spine | 2 | 1987 | 32 |
Why?
|
Agnosia | 1 | 1998 | 3 |
Why?
|
Putamen | 1 | 1998 | 10 |
Why?
|
Dermatitis, Allergic Contact | 1 | 1998 | 9 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 71 |
Why?
|
Combined Modality Therapy | 2 | 1986 | 219 |
Why?
|
Hypersensitivity, Delayed | 1 | 1998 | 35 |
Why?
|
Postoperative Care | 2 | 1988 | 84 |
Why?
|
Pyridoxal Phosphate | 1 | 1997 | 8 |
Why?
|
Hemianopsia | 1 | 1997 | 5 |
Why?
|
Nitric Oxide | 1 | 2000 | 85 |
Why?
|
Edetic Acid | 1 | 1997 | 41 |
Why?
|
Injections, Intravenous | 2 | 1983 | 105 |
Why?
|
Leukodystrophy, Metachromatic | 1 | 1996 | 3 |
Why?
|
Body Mass Index | 1 | 1998 | 122 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 1996 | 10 |
Why?
|
Hydrocephalus | 1 | 1996 | 20 |
Why?
|
Manganese | 1 | 1997 | 33 |
Why?
|
Orientation | 1 | 1997 | 29 |
Why?
|
Neurons | 1 | 1985 | 195 |
Why?
|
Radiology | 1 | 1996 | 15 |
Why?
|
Dental Prosthesis Design | 1 | 1996 | 12 |
Why?
|
Carotid Artery Diseases | 2 | 1986 | 36 |
Why?
|
Psychomotor Performance | 1 | 1998 | 69 |
Why?
|
Dental Implants | 1 | 1996 | 21 |
Why?
|
Patient Care Planning | 1 | 1996 | 55 |
Why?
|
Mandible | 1 | 1996 | 32 |
Why?
|
Drug Tolerance | 1 | 1996 | 26 |
Why?
|
Endarterectomy, Carotid | 1 | 1996 | 16 |
Why?
|
Remission Induction | 1 | 1996 | 64 |
Why?
|
Apoptosis | 2 | 1999 | 265 |
Why?
|
Cermet Cements | 1 | 1995 | 1 |
Why?
|
Composite Resins | 1 | 1995 | 10 |
Why?
|
Phosphates | 1 | 1996 | 71 |
Why?
|
Dental Amalgam | 1 | 1995 | 8 |
Why?
|
Lumbosacral Region | 3 | 1984 | 10 |
Why?
|
Dental Restoration, Permanent | 1 | 1995 | 16 |
Why?
|
Autonomic Nervous System | 1 | 1995 | 41 |
Why?
|
Angiography | 3 | 1980 | 63 |
Why?
|
Child | 3 | 1991 | 749 |
Why?
|
Regional Blood Flow | 3 | 1995 | 105 |
Why?
|
Mitomycin | 2 | 1983 | 13 |
Why?
|
Intervertebral Disc Displacement | 2 | 1984 | 11 |
Why?
|
Diatrizoate | 2 | 1983 | 15 |
Why?
|
Water | 1 | 1995 | 85 |
Why?
|
Tissue Distribution | 1 | 1995 | 124 |
Why?
|
Infant | 3 | 1991 | 464 |
Why?
|
Data Interpretation, Statistical | 2 | 1996 | 109 |
Why?
|
Equipment Design | 1 | 1995 | 132 |
Why?
|
T-Lymphocytes | 1 | 1998 | 182 |
Why?
|
Iodine | 2 | 1983 | 21 |
Why?
|
Virus Cultivation | 1 | 1993 | 24 |
Why?
|
Infant, Newborn | 2 | 1986 | 389 |
Why?
|
Disease Progression | 2 | 2002 | 244 |
Why?
|
Simplexvirus | 1 | 1993 | 33 |
Why?
|
Predictive Value of Tests | 2 | 2002 | 321 |
Why?
|
Actuarial Analysis | 1 | 1992 | 21 |
Why?
|
Interleukin-6 | 1 | 1995 | 145 |
Why?
|
Nose | 1 | 1992 | 31 |
Why?
|
Carotid Arteries | 2 | 1986 | 51 |
Why?
|
Fluorouracil | 1 | 1992 | 49 |
Why?
|
Case-Control Studies | 2 | 2000 | 283 |
Why?
|
Cisplatin | 1 | 1992 | 43 |
Why?
|
Liver | 1 | 1997 | 248 |
Why?
|
Carbon Dioxide | 2 | 1989 | 90 |
Why?
|
Cerebrospinal Fluid Pressure | 1 | 1992 | 3 |
Why?
|
Dental Pulp | 1 | 1992 | 8 |
Why?
|
Maxillary Sinus | 1 | 1992 | 5 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 1992 | 14 |
Why?
|
Osteotomy | 1 | 1992 | 19 |
Why?
|
Atrophy | 2 | 1989 | 41 |
Why?
|
Drug Administration Schedule | 1 | 1992 | 191 |
Why?
|
Severity of Illness Index | 2 | 2002 | 358 |
Why?
|
DNA, Viral | 1 | 1993 | 98 |
Why?
|
Asphyxia Neonatorum | 1 | 1991 | 8 |
Why?
|
Endarterectomy | 2 | 1986 | 10 |
Why?
|
Blood Flow Velocity | 2 | 2000 | 72 |
Why?
|
Epilepsies, Partial | 1 | 1991 | 11 |
Why?
|
Pilot Projects | 1 | 1992 | 264 |
Why?
|
Video Recording | 1 | 1991 | 46 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 70 |
Why?
|
Databases, Factual | 1 | 2011 | 102 |
Why?
|
Antibodies, Viral | 1 | 1993 | 104 |
Why?
|
Electrocardiography | 1 | 1994 | 132 |
Why?
|
Age of Onset | 1 | 2009 | 64 |
Why?
|
Carbon Radioisotopes | 1 | 1989 | 43 |
Why?
|
Uncertainty | 1 | 2009 | 14 |
Why?
|
Child, Preschool | 2 | 1991 | 554 |
Why?
|
Dogs | 2 | 1986 | 159 |
Why?
|
Principal Component Analysis | 1 | 2008 | 18 |
Why?
|
Optic Nerve | 1 | 1988 | 27 |
Why?
|
Cell Line | 1 | 1993 | 375 |
Why?
|
Orbit | 1 | 1988 | 28 |
Why?
|
Glutamine | 1 | 2008 | 27 |
Why?
|
Cerebral Infarction | 1 | 1988 | 36 |
Why?
|
Protons | 1 | 2008 | 30 |
Why?
|
Ependymoma | 1 | 1987 | 10 |
Why?
|
Glutamic Acid | 1 | 2008 | 66 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 141 |
Why?
|
Hexokinase | 1 | 1987 | 5 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 1986 | 3 |
Why?
|
Radiotherapy | 1 | 1988 | 73 |
Why?
|
Biological Markers | 2 | 1999 | 262 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 402 |
Why?
|
Cerebral Angiography | 2 | 1983 | 33 |
Why?
|
Ioxaglic Acid | 1 | 1986 | 5 |
Why?
|
Isotonic Solutions | 1 | 1986 | 16 |
Why?
|
Multivariate Analysis | 1 | 2008 | 225 |
Why?
|
Intracranial Arteriosclerosis | 1 | 1986 | 6 |
Why?
|
Diabetic Neuropathies | 1 | 1986 | 16 |
Why?
|
Analysis of Variance | 1 | 2008 | 339 |
Why?
|
Melanoma | 1 | 1987 | 87 |
Why?
|
Chemical Phenomena | 1 | 1985 | 43 |
Why?
|
Chemistry | 1 | 1985 | 43 |
Why?
|
Metabolic Clearance Rate | 1 | 1985 | 31 |
Why?
|
Alzheimer Disease | 1 | 1989 | 71 |
Why?
|
Calcium | 1 | 1992 | 208 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2005 | 18 |
Why?
|
Angina Pectoris | 1 | 2005 | 31 |
Why?
|
Cerebral Ventricles | 2 | 1992 | 32 |
Why?
|
Ischemic Attack, Transient | 1 | 2005 | 28 |
Why?
|
Electric Stimulation Therapy | 1 | 2005 | 16 |
Why?
|
Nausea | 4 | 1983 | 34 |
Why?
|
Spectrometry, Fluorescence | 1 | 1984 | 59 |
Why?
|
Tibia | 1 | 2003 | 34 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1989 | 431 |
Why?
|
Desensitization, Immunologic | 1 | 1983 | 9 |
Why?
|
Physical Exertion | 1 | 2003 | 46 |
Why?
|
Anaphylaxis | 1 | 1983 | 17 |
Why?
|
Polyethylene Glycols | 1 | 1983 | 45 |
Why?
|
Cerebellum | 1 | 2003 | 59 |
Why?
|
Pulsatile Flow | 1 | 2002 | 13 |
Why?
|
Physical Stimulation | 1 | 2002 | 28 |
Why?
|
Sulfoglycosphingolipids | 1 | 2002 | 1 |
Why?
|
Drug Hypersensitivity | 1 | 1983 | 26 |
Why?
|
Time | 1 | 2002 | 41 |
Why?
|
Somatosensory Cortex | 1 | 2002 | 24 |
Why?
|
Seizures | 1 | 2003 | 79 |
Why?
|
Recovery of Function | 1 | 2002 | 91 |
Why?
|
Headache | 3 | 1984 | 39 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2003 | 176 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2002 | 45 |
Why?
|
Circle of Willis | 1 | 2000 | 2 |
Why?
|
Adenosine Triphosphate | 1 | 2003 | 121 |
Why?
|
Temporal Bone | 1 | 2000 | 11 |
Why?
|
Cerebral Arteries | 1 | 2000 | 31 |
Why?
|
Comorbidity | 1 | 2002 | 190 |
Why?
|
Pressure | 1 | 2000 | 79 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2000 | 15 |
Why?
|
Technetium Tc 99m Exametazime | 1 | 2000 | 3 |
Why?
|
Electromagnetic Fields | 1 | 2000 | 14 |
Why?
|
Nitrates | 1 | 2000 | 27 |
Why?
|
Statistics as Topic | 1 | 2000 | 133 |
Why?
|
Radiopharmaceuticals | 1 | 2000 | 37 |
Why?
|
Osteoarthritis | 1 | 2001 | 51 |
Why?
|
Patient Selection | 1 | 2001 | 155 |
Why?
|
Diagnostic Errors | 1 | 1980 | 73 |
Why?
|
Models, Theoretical | 1 | 2000 | 124 |
Why?
|
Neoplasm Staging | 1 | 1980 | 125 |
Why?
|
Serum Albumin | 1 | 1999 | 55 |
Why?
|
Cohort Studies | 1 | 2002 | 332 |
Why?
|
Age Factors | 1 | 2002 | 480 |
Why?
|
Eyeglasses | 1 | 1997 | 9 |
Why?
|
Ear, External | 1 | 1997 | 23 |
Why?
|
Parietal Lobe | 1 | 1997 | 17 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1997 | 53 |
Why?
|
Interleukin-10 | 1 | 1997 | 38 |
Why?
|
Diffuse Cerebral Sclerosis of Schilder | 1 | 1996 | 1 |
Why?
|
Arousal | 1 | 1997 | 37 |
Why?
|
Epitopes | 1 | 1998 | 86 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 224 |
Why?
|
Reaction Time | 1 | 1998 | 81 |
Why?
|
Interleukin-8 | 1 | 1997 | 54 |
Why?
|
Tomography, X-Ray | 1 | 1996 | 8 |
Why?
|
Acute Disease | 1 | 1999 | 271 |
Why?
|
Mandibular Diseases | 1 | 1996 | 11 |
Why?
|
Visual Fields | 1 | 1997 | 22 |
Why?
|
Alveolar Process | 1 | 1996 | 10 |
Why?
|
Cadaver | 1 | 1996 | 51 |
Why?
|
Radiographic Image Enhancement | 1 | 1996 | 29 |
Why?
|
Liver Neoplasms | 1 | 1997 | 97 |
Why?
|
Drug Evaluation | 2 | 1984 | 54 |
Why?
|
Bone and Bones | 1 | 1999 | 99 |
Why?
|
Urethane | 1 | 1995 | 2 |
Why?
|
Polyurethanes | 1 | 1995 | 5 |
Why?
|
Risk | 2 | 1986 | 203 |
Why?
|
Bisphenol A-Glycidyl Methacrylate | 1 | 1995 | 3 |
Why?
|
Sepharose | 1 | 1995 | 13 |
Why?
|
Dental Alloys | 1 | 1995 | 10 |
Why?
|
Nickel | 1 | 1995 | 21 |
Why?
|
Cold Temperature | 1 | 1995 | 59 |
Why?
|
Acrylic Resins | 1 | 1995 | 22 |
Why?
|
Gels | 1 | 1995 | 35 |
Why?
|
Sensory Receptor Cells | 1 | 1995 | 20 |
Why?
|
Temperature | 1 | 1995 | 137 |
Why?
|
Bone Resorption | 1 | 1996 | 49 |
Why?
|
Interleukin-1 | 1 | 1995 | 109 |
Why?
|
Spinal Nerve Roots | 1 | 1993 | 14 |
Why?
|
Nerve Compression Syndromes | 1 | 1993 | 14 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1997 | 210 |
Why?
|
Maxillary Nerve | 1 | 1992 | 1 |
Why?
|
Maxillary Sinusitis | 1 | 1992 | 1 |
Why?
|
Hypesthesia | 1 | 1992 | 6 |
Why?
|
Intracranial Pressure | 1 | 1992 | 15 |
Why?
|
Skin Physiological Phenomena | 1 | 1992 | 11 |
Why?
|
Sensation | 1 | 1992 | 18 |
Why?
|
Surgical Flaps | 1 | 1992 | 51 |
Why?
|
Wound Healing | 1 | 1992 | 106 |
Why?
|
Pain | 2 | 1983 | 191 |
Why?
|
Anuria | 1 | 1988 | 5 |
Why?
|
Astrocytoma | 1 | 1988 | 26 |
Why?
|
Sheep | 1 | 1988 | 46 |
Why?
|
Cerebral Hemorrhage | 1 | 1988 | 45 |
Why?
|
Epidural Space | 1 | 1987 | 3 |
Why?
|
Radiation Injuries | 1 | 1988 | 63 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 1986 | 10 |
Why?
|
False Negative Reactions | 1 | 1986 | 53 |
Why?
|
Meningioma | 1 | 1986 | 26 |
Why?
|
Technetium | 1 | 1986 | 23 |
Why?
|
False Positive Reactions | 1 | 1986 | 71 |
Why?
|
Injections | 1 | 1986 | 53 |
Why?
|
Autoradiography | 1 | 1986 | 73 |
Why?
|
Nervous System Diseases | 1 | 1987 | 78 |
Why?
|
Spinal Stenosis | 1 | 1984 | 10 |
Why?
|
Urticaria | 1 | 1983 | 14 |
Why?
|
Ions | 1 | 1983 | 29 |
Why?
|
Vomiting | 1 | 1983 | 45 |
Why?
|
Risk Factors | 1 | 1988 | 555 |
Why?
|
Blood Pressure | 1 | 1983 | 205 |
Why?
|
Heart Rate | 1 | 1983 | 138 |
Why?
|
